Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cramped chromatin regulator homolog 1 (CRAMP1) is a protein-coding gene highly conserved, with predicted functions in chromatin binding and nuclear pattern specification. Its molecular activity centers on possible regulation of gene expression through interactions with chromatin, though its specific functions in humans remain incompletely characterized. CRAMP1 is associated with developmental processes and has been implicated in rare syndromes such as alpha thalassemia-intellectual disability syndrome type 1. There is currently no evidence that CRAMP1 acts as a receptor, enzyme, or therapeutic target, and no drugs or biomarkers have been developed in relation to this gene. It is widely expressed across tissues, but its precise physiological and pathological roles require further clarification[1][2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cramped chromatin regulator homolog 1 (CRAMP1).